Loss of Egr1, a human del5q gene, accelerates BCR-ABL driven chronic myelogenous leukemia.

Maifrede, Silvia; Magimaidas, Andrew; Sha, Xiaojin; Mukherjee, Kaushiki; Liebermann, Dan A; Hoffman, Barbara

Maifrede, Silvia; Magimaidas, Andrew; Sha, Xiaojin; Mukherjee, Kaushiki; Liebermann, Dan A; Hoffman, Barbara.

Afiliação

Maifrede S; Fels Institute for Cancer Research and Molecular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
Magimaidas A; Department of Microbiology and Immunology, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
Sha X; Fels Institute for Cancer Research and Molecular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
Mukherjee K; Current address: Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania.
Liebermann DA; Fels Institute for Cancer Research and Molecular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.
Hoffman B; Fels Institute for Cancer Research and Molecular Biology, Temple University Lewis Katz School of Medicine, Philadelphia, PA, USA.

Oncotarget ; 8(41): 69281-69294, 2017 Sep 19.

Article em En | MEDLINE | ID: mdl-29050203

Palavras-chave

Egr1; Leukemic stem cells; chronic myelogenous leukemia; stress response protein; tumor suppressor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia / Tratamento Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google